Laser-engineered dissolving microneedles for active transdermal delivery of nadroparin calcium

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 82, Issue 2, 2012, Pages 299-307

  Gomaa, Yasmine A ^a,c   Garland, Martin J ^b   McInnes, Fiona ^a,d   El Khordagui, Labiba K ^c   Wilson, Clive ^a   Donnelly, Ryan F ^b  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c Alexandria University Faculty of Pharmacy   (Egypt)

^d GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Anti factor Xa activity; Dissolving microneedles; Low molecular weight heparin; Nadroparin calcium; Transdermal permeation

Indexed keywords

NADROPARIN; PENETRATION ENHANCING AGENT; POLY(METHYLVINYLETHER CO MALEIC ANHYDRIDE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; DERMATOME; DISSOLVING MICRONEEDLE; DRUG DELIVERY SYSTEM; DRUG RELEASE; HUMAN; HUMAN TISSUE; MACROMOLECULE; NEEDLE; PHARMACEUTICAL ENGINEERING; SKIN PERMEABILITY;

ADMINISTRATION, CUTANEOUS; AGED; ANIMALS; DRUG DELIVERY SYSTEMS; FEMALE; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; LASERS; MACROMOLECULAR SUBSTANCES; MICROINJECTIONS; NADROPARIN; NEEDLES; PERMEABILITY; SKIN; SKIN ABSORPTION; SWINE;

EID: 84867839667     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2012.07.008     Document Type: Article

References (53)

1. L. Harrison, J. McGinnis, M. Crowther, J. Ginsberg, and J. Hirsh Assessment of outpatient treatment of deep-vein thrombosis with low-molecular-weight heparin Arch. Intern. Med. 158 1998 2001 2003 (Pubitemid 28465624)
2. T.M. Hyers, G. Agnelli, R.D. Hull, J.G. Weg, T.A. Morris, M. Samama, and V. Tapson Antithrombotic therapy for venous thromboembolic disease Chest 114 1998 561S 578S (Pubitemid 28535781)
3. Y.K. Song, and C.K. Kim Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes Biomaterials 27 2006 271 280
4. J. Hirsh, T.E. Warkentin, S.G. Shaughnessy, S.S. Anand, J.L. Halperin, R. Raschke, C. Granger, E.M. Ohman, and J.E. Dalen Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety Chest 119 2001 64S 94S (Pubitemid 32154195)
5. C.J. Carter, J.G. Kelton, J. Hirsh, A. Cerskus, A.V. Santos, and M. Gent The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits Blood 59 1982 1239 1245 (Pubitemid 12074853)
6. A.M. Frydman, L. Bara, Y. Le Roux, M. Woler, F. Chauliac, and M.M. Samama The antithrombotic activity and pharmacokinetics of enoxaparine, a low molecular weight heparin, in humans given single subcutaneous doses of 20 to 80 mg J. Clin. Pharmacol. 28 1988 609 618 (Pubitemid 19013395)
7. C. Liautard, A.M. Nunes, T. Vial, F. Chatillon, C. Guy, M. Ollagnier, and J. Descotes Low-molecular-weight heparins and thrombocytosis Ann. Pharmacother. 36 2002 1351 1354 (Pubitemid 34925267)
8. A. Frydman Low-molecular weight heparins: an overview of their pharmacodynamics, pharmacokinetics and metabolism in humans Hemastatis 26 1996 24 38 (Pubitemid 26099958)
9. S. Mitragotri, and J. Kost Transdermal delivery of heparin and low-molecular weight heparin using low-frequency ultrasound Pharm. Res. 18 2001 1151 1156 (Pubitemid 32900401)
10. National Patient Safety Agency, Reducing treatment dose errors with low molecular weight heparins, NPSA/2010/RRR014, 2010.
11. N.A. Motlekar, and B.B. Youan The quest for non-invasive delivery of bioactive macromolecules: a focus on heparins J. Control. Release 113 2006 91 101 (Pubitemid 43928148)
12. A. Nissan, E. Ziv, M. Kidron, H. Bar-On, G. Friedman, E. Hyam, and A. Eldor Intestinal absorption of low molecular weight heparin in animals and human subjects Haemostasis 30 2000 225 232 (Pubitemid 32225727)
13. J. Arnold, F. Ahsan, E. Meezan, and D.J. Pillion Nasal administration of low molecular weight heparin J. Pharm. Sci. 91 2002 1707 1714 (Pubitemid 34680234)
14. F. Mustafa, T. Yang, M.A. Khan, and F. Ahsan Chain length-dependent effects of alkylmaltosides on nasal absorption of enoxaparin J. Pharm. Sci. 93 2004 675 683 (Pubitemid 38332300)
15. Y. Qi, G. Zhao, D. Liu, Z. Shriver, M. Sundaram, S. Sengupta, G. Venkataraman, R. Langer, and R. Sasisekharan Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route Proc. Natl. Acad. Sci. USA 101 2004 9867 9872 (Pubitemid 38869328)
16. T. Yang, F. Mustafa, S. Bai, and F. Ahsan Pulmonary delivery of low molecular weight heparins Pharm. Res. 21 2004 2009 2016 (Pubitemid 40941220)
17. S.S. Lanke, C.S. Kolli, J.G. Strom, and A.K. Banga Enhanced transdermal delivery of low molecular weight heparin by barrier perturbation Int. J. Pharm. 365 2009 26 33
18. G.L. Xiong, D. Quan, and H.I. Maibach Effects of penetration enhancers on in vitro percutaneous absorption of low molecular weight heparin through human skin J. Control. Release 42 1996 289 296 (Pubitemid 26338603)
19. S. Mitragotri Healing sound: the use of ultrasound in drug delivery and other therapeutic applications Nat. Rev. Drug Discov. 4 2005 255 260 (Pubitemid 40372559)
20. S. Pacini, T. Punzi, M. Gulisano, F. Cecchi, S. Vannucchi, and M. Ruggiero Transdermal delivery of heparin using pulsed current iontophoresis Pharm. Res. 23 2006 114 120 (Pubitemid 43214667)
21. G. Betz, P. Nowbakht, R. Imboden, and G. Imanidis Heparin penetration into and permeation through human skin from aqueous and liposomal formulations in vitro Int. J. Pharm. 228 2001 147 159 (Pubitemid 32905374)
22. Y.K. Song, S.Y. Hyun, H.T. Kim, C.K. Kim, and J.M. Oh Transdermal delivery of low molecular weight heparin loaded in flexible liposomes with bioavailability enhancement: comparison with ethosomes J. Microencapsul. 28 2011 151 158
23. D.V. McAllister, P.M. Wang, S.P. Davis, J.H. Park, P.J. Canatella, M.G. Allen, and M.R. Prausnitz Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: fabrication methods and transport studies Proc. Natl. Acad. Sci. USA 100 2003 13755 13760 (Pubitemid 37499139)
24. M.R. Prausnitz Microneedles for transdermal drug delivery Adv. Drug Deliv. Rev. 56 2004 581 587 (Pubitemid 38326934)
25. R.F. Donnelly, T.R. Raj Singh, and A.D. Woolfson Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety Drug Deliv. 17 2010 187 207
26. S.H. Bariya, M.C. Gohel, T.A. Mehta, and O.P. Sharma Microneedles: an emerging transdermal drug delivery system J. Pharm. Pharmacol. 64 2012 11 29
27. Y. Ito, A. Murakami, T. Maeda, N. Sugioka, and K. Takada Evaluation of self-dissolving needles containing low molecular weight heparin (LMWH) in rats Int. J. Pharm. 349 2008 124 129 (Pubitemid 350299697)
28. Y.A. Gomaa, D.I. Morrow, M.J. Garland, R.F. Donnelly, L.K. El-Khordagui, and V.M. Meidan Effects of microneedle length, density, insertion time and multiple applications on human skin barrier function: assessments by transepidermal water loss Toxicol. In Vitro 24 2010 1971 1978
29. R.F. Donnelly, R. Majithiya, T.R.R. Singh, D.I.J. Morrow, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, and A.D. Woolfson Design, optimization and characterization of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique Pharm. Res. 28 2011 41 57
30. R.J. Scheuplein Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration J. Invest. Dermatol. 48 1967 79 88
31. B. Mulloy, J. Hogwood, and E. Gray Assays and reference materials for current and future applications of heparins Biologicals 38 2010 459 466
32. M. Sznitowska, and S. Janicki Percutaneous absorption of heparin: a critical review of experimental results Pol. Merkur. Lekarski 7 2000 58 63
33. V.P. Shah Transdermal drug delivery system regulatory issues R.H. Guy, J. Hadgraft, Transdermal Drug Delivery 2003 Marcel Dekker Inc. New York 361 367
34. R.F. Donnelly, R. Majithiya, R.R.S. Thakur, D.I.J. Desmond, M.J. Garland, Y.K. Demir, K. Migalska, E. Ryan, D. Gillen, C.J. Scott, and A.D. Woolfson Design and physicochemical characterization of optimized polymeric microneedle arrays prepared by a novel laser-based micromoulding technique Pharm. Res. 28 2011 41 57
35. J.H. Park, M.G. Allen, and M.R. Prausnitz Polymer microneedles for controlled-release drug delivery Pharm. Res. 23 2006 1008 1019 (Pubitemid 43781409)
36. J.W. Lee, J.H. Park, and M.R. Prausnitz Dissolving microneedles for transdermal drug delivery Biomaterials 29 2008 2113 2124
37. M.R. Prausnitz, E.R. Edelman, J.A. Gimm, R. Langer, and J.C. Weaver Transdermal delivery of heparin by skin electroporation Nat. Biotechnol. 13 1995 1205 1209
38. C. Parisel, L. Saffar, L. Gattegno, V. Andre, N. Abdul-Malak, E. Perrier, and D. Letourneur Interactions of heparin with human skin cells: binding, location, and transdermal penetration J. Biomed. Mater. Res. A 67 2003 517 523 (Pubitemid 37522458)
39. K. Hozumi, N. Suzuki, P.K. Nielsen, M. Nomizu, and Y. Yamada Laminin alpha1 chain LG4 module promotes cell attachment through syndecans and cell spreading through integrin alpha2beta1 J. Biol. Chem. 281 2006 32929 32940 (Pubitemid 46036848)
40. R.F. Donnelly, M.J. Garland, D.I.J. Morrow, K. Migalska, T.R.R. Singh, R. Majithiya, and A.D. Woolfson Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution J. Control. Release 147 2010 333 341
41. S. Mitragotri, D. Blankschtein, and R. Langer Transdermal drug delivery using low-frequency sonophoresis Pharm. Res. 13 1996 411 420 (Pubitemid 26114728)
42. G. Li, A. Badkar, S. Nema, C.S. Kolli, and A.K. Banga In vitro transdermal delivery of therapeutic antibodies using maltose microneedles Int. J. Pharm. 368 2009 109 115
43. W. Martanto, J.S. Moore, T. Couse, and M.R. Prausnitz Mechanism of fluid infusion during microneedle insertion and retraction J. Control. Release 112 2006 357 361 (Pubitemid 43737149)
44. M. Shirkhanzadeh Microneedles coated with porous calcium phosphate ceramics: effective vehicles for transdermal delivery of solid trehalose J. Mater. Sci. Mater. Med. 16 2005 37 45 (Pubitemid 40476215)
45. G. Yan, K.S. Warner, J. Zhang, S. Sharma, and B.K. Gale Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery Int. J. Pharm. 391 2010 7 12
46. M.J. Garland, E. Caffarel-Salvador, K. Migalska, A.D. Woolfson, and R.F. Donnelly Dissolving polymeric microneedle arrays for electrically assisted transdermal drug delivery J. Control. Release 159 2012 52 59
47. M.A. Kendall, Y.F. Chong, and A. Cock The mechanical properties of the skin epidermis in relation to targeted gene and drug delivery Biomaterials 28 2007 4968 4977 (Pubitemid 47362353)
48. M.L. Crichton, A. Ansaldo, X. Chen, T.W. Prow, G.J. Fernando, and M.A. Kendall The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine Biomaterials 31 2010 4562 4572
49. N. Roxhed, T.C. Gasser, P. Griss, G.A. Holzapfel, and G. Stemme Penetration-enhanced ultrasharp microneedles and prediction on skin interaction for efficient transdermal drug delivery J. Microelectromech. Syst. 16 2007 1429 1440 (Pubitemid 350239136)
50. S. Aoyagi, H. Izumi, and M. Fukuda Biodegradable polymer needle with various tip angles and consideration on insertion mechanism of mosquito's proboscis Sens. Act. A 143 2008 20 28 (Pubitemid 351417355)
51. X. Kong, and C. Wu Measurement and prediction of insertion force for the mosquito fascicle penetrating into human skin J. Bionic. Eng. 6 2009 143 152
52. K. Migalska, D.I. Morrow, M.J. Garland, R. Thakur, A.D. Woolfson, and R.F. Donnelly Laser-engineered dissolving microneedle arrays for transdermal macromolecular drug delivery Pharm. Res. 28 2011 1919 1930
53. C.F. Lacy, L.L. Armstrong, M.P. Goldman, L.L. Lance, Nadroparin 14th ed., Lexi-Comp, Hudson, Ohio, 2006-2007, pp. 1181-1182.